Description
PRICE CHANGE VYLOY
Base award description: BPA FOR XTANDI, XOSPATA.
First action · last action
2021-10-06 · 2026-01-20
Transactions
21
First transaction's obligation
$0
Base + all options value (sum of deltas)
$296,500
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79721D0260
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 21 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2021-10-06+$0= $0
- Mod P000012021-12-07+$0= $0
- Mod P000022021-12-07+$0= $0
- Mod P000032022-09-06+$0= $0
- Mod P000042022-12-12+$0= $0
- Mod P000052022-12-12+$0= $0
- Mod P000062023-09-05+$0= $0
- Mod P000072023-11-20+$0= $0
- Mod P000082023-12-12+$0= $0
- Mod P000092024-09-26+$0= $0
- Mod P000102024-12-20+$0= $0
- Mod P000112024-12-20+$0= $0
- Mod P000122024-12-23+$0= $0
- Mod P000132025-01-27+$0= $0
- Mod P000142025-02-26+$0= $0
- Mod P000152025-06-10+$0= $0
- Mod P000162025-07-09+$0= $0
- Mod P000172025-09-08+$0= $0
- Mod P000182025-12-08+$0= $0
- Mod P000192025-12-17+$0= $0
- Mod P000202026-01-20+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2021-10-06 | +$0 | $0 | BPA FOR XTANDI, XOSPATA. |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-12-07 | +$0 | $0 | 2022 PUBLIC LAW UPDATES-XTANDI, XOSPATA. |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-12-07 | +$0 | $0 | TEMPORARY PRICE REDUCTION (TPR) FOR XTANDI. |
| Mod P00003· EXERCISE AN OPTION | 2022-09-06 | +$0 | $0 | EXERCISE THE FIRST OPTION YEAR ON BPA 36E79722A0001 |
| Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-12-12 | +$0 | $0 | 2023 PUBLIC LAW UPDATES |
| Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-12-12 | +$0 | $0 | TEMPORARY PRICE REDUCTION - XTANDI |
| Mod P00006· EXERCISE AN OPTION | 2023-09-05 | +$0 | $0 | OPTION YEAR 2 - BPA 36E79722A0001 |
| Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-11-20 | +$0 | $0 | 2024 PUBLIC LAW PRICING UPDATES |
| Mod P00008· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-12-12 | +$0 | $0 | TEMPORARY PRICE REDUCTION |
| Mod P00009· EXERCISE AN OPTION | 2024-09-26 | +$0 | $0 | EXERCISE OPTION YEAR 3 |
| Mod P00010· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-12-20 | +$0 | $0 | 2025 PUBLIC LAW PRICING UPDATES |
| Mod P00011· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-12-20 | +$0 | $0 | TEMPORARY PRICE REDUCTION |
| Mod P00012· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-12-23 | +$0 | $0 | VYLOY PRODUCT ADDITION |
| Mod P00013· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-01-27 | +$0 | $0 | IZERVAY PRODUCT ADDITION |
| Mod P00014· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-02-26 | +$0 | $0 | ZYLOY PRICE CHANGE |
| Mod P00015· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-06-10 | +$0 | $0 | ZYLOY PRICE CHANGE AND PRODUCT ADDITION |
| Mod P00016· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-07-09 | +$0 | $0 | ZYLOY PRICE CHANGE |
| Mod P00017· EXERCISE AN OPTION | 2025-09-08 | +$0 | $0 | EXERCISE 4TH OPTION YEAR |
| Mod P00018· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-12-08 | +$0 | $0 | 2026 PUBLIC LAW PRICING UPDATES. |
| Mod P00019· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-12-17 | +$0 | $0 | 2026 TPR |
| Mod P00020· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2026-01-20 | +$0 | $0 | PRICE CHANGE VYLOY |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NKGHPQKJQWC1)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36F79721D0260 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2021 |
| 36E79719A0025 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2019 |
| VA24817F2692 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $145,897 | FY2017 |
| VA24817F2026 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 3650 · CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY | $243,162 | FY2017 |
| VA24817F0523 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $243,162 | FY2017 |
| VA24117J0582 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $108,180 | FY2017 |
Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36E79726A0025 | CHIESI USA INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0024 | NEUROTECH PHARMACEUTICALS, INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0023 | TAKEDA PHARMACEUTICALS AMERICA, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726D0041 | GOLDEN STATE MEDICAL SUPPLY, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0022 | AURINIA PHARMA US INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36E79722A0001_3600 · retrieved 2026-09-26.